Total Payments
$2,185
2024 Payments
$1,512
Companies
21
Transactions
125
Medicare Patients
2,670
Medicare Billing
$59,074
Payment Breakdown by Category
Food & Beverage$2,185 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,185 | 125 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $384.55 | 24 | $0 (2024) |
| ABBVIE INC. | $303.33 | 17 | $0 (2024) |
| PFIZER INC. | $270.66 | 16 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $269.88 | 15 | $0 (2024) |
| Lilly USA, LLC | $175.53 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $137.55 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $104.02 | 4 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $102.48 | 5 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $87.64 | 5 | $0 (2024) |
| Amgen Inc. | $72.93 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,512 | 89 | Novo Nordisk Inc ($317.96) |
| 2023 | $539.11 | 28 | ABBVIE INC. ($90.06) |
| 2022 | $121.93 | 7 | OptiNose US, Inc. ($37.44) |
| 2021 | $11.86 | 1 | Lilly USA, LLC ($11.86) |
All Payment Transactions
125 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: PAIN | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: PAIN | ||||||
| 11/26/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Inflammation | ||||||
| 11/25/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: VACCINES | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: PAIN | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Inflammation | ||||||
| 10/28/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $0.56 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Obesity | ||||||
| 10/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.28 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: PAIN | ||||||
| 10/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/07/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 501 | 548 | $25,652 | $13,077 |
| 2022 | 21 | 944 | 1,020 | $34,923 | $22,304 |
| 2021 | 18 | 727 | 754 | $23,054 | $15,622 |
| 2020 | 14 | 498 | 506 | $12,850 | $8,070 |
Total Patients
2,670
Total Services
2,828
Medicare Billing
$59,074
Procedure Codes
69
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 57 | $9,814 | $4,517 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 24 | 24 | $2,931 | $2,521 | 86.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 33 | $3,982 | $1,815 | 45.6% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 12 | 12 | $1,060 | $572.34 | 54.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 54 | 54 | $788.08 | $558.90 | 70.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 18 | 18 | $788.25 | $522.18 | 66.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 30 | 31 | $793.81 | $510.26 | 64.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 59 | 59 | $677.04 | $448.99 | 66.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 25 | 25 | $552.51 | $328.00 | 59.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 54 | $304.12 | $267.96 | 88.1% |
| 83721 | Ldl cholesterol level | Office | 2023 | 25 | 25 | $359.00 | $257.25 | 71.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 26 | $1,210 | $210.45 | 17.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 19 | $302.44 | $180.88 | 59.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 12 | 12 | $292.48 | $177.36 | 60.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 46 | 47 | $257.33 | $146.17 | 56.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 52 | $1,540 | $43.82 | 2.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 99 | 103 | $9,476 | $5,690 | 60.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $4,663 | $4,408 | 94.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 39 | $5,347 | $2,808 | 52.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 67 | 68 | $1,599 | $1,126 | 70.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 93 | 99 | $1,291 | $1,031 | 79.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 14 | 14 | $970.98 | $952.00 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 103 | 108 | $1,144 | $827.24 | 72.3% |
| 82306 | Vitamin d-3 level | Office | 2022 | 27 | 27 | $986.85 | $787.07 | 79.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 56 | 59 | $1,084 | $777.92 | 71.8% |
About Albert Lusby, FNP
Albert Lusby, FNP is a Nurse Practitioner healthcare provider based in Amarillo, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2010. The National Provider Identifier (NPI) number assigned to this provider is 1598077935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Albert Lusby, FNP has received a total of $2,185 in payments from pharmaceutical and medical device companies, with $1,512 received in 2024. These payments were reported across 125 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,185).
As a Medicare-enrolled provider, Lusby has provided services to 2,670 Medicare beneficiaries, totaling 2,828 services with total Medicare billing of $59,074. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Amarillo, TX
- Active Since 07/13/2010
- Last Updated 07/13/2010
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1598077935
Products in Payments
- JARDIANCE (Drug) $164.80
- Wegovy (Drug) $160.68
- FARXIGA (Drug) $157.90
- NURTEC ODT (Drug) $152.85
- UBRELVY (Drug) $142.53
- PREVNAR 20 (Biological) $129.66
- Rybelsus (Drug) $122.21
- LEQVIO (Drug) $104.02
- XIFAXAN (Drug) $102.48
- Ozempic (Drug) $101.66
- AIRSUPRA (Drug) $94.00
- MOUNJARO (Drug) $89.14
- VOQUEZNA (Drug) $87.64
- VRAYLAR (Drug) $87.36
- Otezla (Drug) $59.15
- QULIPTA (Drug) $51.44
- Veozah (Drug) $45.81
- TRULICITY (Drug) $40.27
- TRELEGY ELLIPTA (Drug) $40.01
- Xhance (Drug) $37.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Amarillo
Sue Rankin, Np, NP
Nurse Practitioner — Payments: $68,235
Nurse Practitioner $68,235
Kathy Ford, Fnp-C, FNP-C
Nurse Practitioner — Payments: $6,965
Nurse Practitioner $6,965
Ms. Susan Baltz, Fnp, FNP
Nurse Practitioner — Payments: $4,909
Nurse Practitioner $4,909
William Ledford, Fnp, FNP
Nurse Practitioner — Payments: $3,688
Nurse Practitioner $3,688
Connie Mccoy, Fnp-C, FNP-C
Nurse Practitioner — Payments: $3,626
Nurse Practitioner $3,626
Kate Bridges, Np, NP
Nurse Practitioner — Payments: $3,525
Nurse Practitioner $3,525